Saturday 17 October 2026 Export UTMD’s income statement to Excel — free account

Utah Medical Products, Inc.

UTMD Healthcare Medical Instruments & Supplies

Utah Medical Products, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, down 5.83% from fiscal 2024. In the quarter to June 2026, revenue fell 14.3%, EPS fell 10.6% and free cash flow fell 55.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years.

74.51 0.41 −0.55%

Follow UTMD

Alert me

Market cap: $237.8M
P/E: 22.7×
Fwd P/E: 28.7×
Dividend yield: 1.66%
F-score: 6/9
Altman Z: 36.25
Beneish M: −2.68
Dividend safety: 82/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	17.79	16.08	18.34	21.03
P/S ratio Full definition →		5.23	4.71	5.26	6.08
P/FCF ratio Full definition →		14.55	12.66	15.16	19.19
P/Operating CF Full definition →		52.07	52.15	63.51	158.81
P/B ratio Full definition →		1.71	1.52	1.64	1.80
Price to Tangible BV Full definition →		1.96	1.74	1.86	2.04
EV/Sales Full definition →		3.07	2.51	2.96	3.69
EV/EBITDA Full definition →		7.98	6.70	8.05	10.46
EV/Operating CF Full definition →		8.38	6.57	8.32	11.23
EV/FCF Full definition →		8.55	6.74	8.53	11.63
Quick Ratio Full definition →		29.22	34.36	25.97	44.01
Current Ratio Full definition →		32.06	37.62	28.64	48.62
Net Debt/EBITDA Full definition →		(24.93)	(26.78)	(26.87)	(30.29)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.31	0.31	0.30	0.29
Operating CF/Net income Full definition →		1.47	1.36	1.19	0.51
Capex/Depreciation Full definition →		(0.04)	(0.14)	(0.19)	(0.56)
Research and Development Expense of Revenue Full definition →		1.70%	2.34%	1.77%	1.81%
Selling, General and Administrative Expense of Revenue Full definition →		28.80%	28.86%	29.39%	22.92%
Intangible Assets out of Total Assets Full definition →		0.13	0.12	0.11	0.11
Share Based Compensation of Revenue Full definition →		0.96%	1.23%	1.38%	0.84%
Graham Net Nets Full definition →		0.46	0.52	0.49	0.45
Graham Number Full definition →		54.19	53.69	53.61	53.18
Earnings Yield Full definition →		5.62%	6.22%	5.45%	4.76%
Free Cash Flow Yield Full definition →		6.87%	7.90%	6.59%	5.21%
Revenue per Share Full definition →		3.06	2.79	2.74	2.68
Operating CF per Share Full definition →		1.21	1.07	0.98	0.43
Capex per Share Full definition →		(0.01)	(0.03)	(0.04)	(0.04)
Free Cash Flow per Share Full definition →		1.20	1.04	0.94	0.39
Cash per Share Full definition →		26.28	26.47	27.44	27.49
Shareholders Equity per Share Full definition →		36.87	36.81	37.79	38.33
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		36.87	36.81	37.79	38.33
Free Cash Flow Full definition →		3.85	3.37	2.98	1.25
Working Capital Full definition →		93.52	95.14	96.87	98.57
Capital Expenditures Full definition →		(0.03)	(0.11)	(0.13)	(0.13)
Net Current Asset Value Full definition →		92.81	94.47	96.37	98.10
EV/EBIT Full definition →		9.98	8.47	10.26	12.96
Capex to Sales Full definition →		0.00	0.01	0.01	0.02
Price to Operating Income Full definition →		16.98	15.90	18.26	21.39
Other line items
Average Receivables Full definition →		3.72	3.81	3.79	3.60
Average Payables Full definition →		0.88	0.80	1.05	0.81
Average Inventory Full definition →		8.61	8.37	8.69	8.62
Average Assets Full definition →		125.83	122.54	123.45	122.69
Average Common Equity Full definition →		121.22	118.35	118.71	119.78

Fold the line items

Columns are period end dates

Stockrow Weekly